Abstract
This study was carried out to determine lumbar and femoral bone mineral density (BMD) in patients with familial Mediterranean fever (FMF), an autosomal-recessive disease characterized by recurrent episodes of peritonitis, pleuritis, and arthritis, which are usually associated with fever. In patients with FMF and control subjects, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured. BMD was determined at the lumbar spine (L1–4) and the femoral regions (neck and total) using dual energy X-ray absorptiometry. Twenty-eight FMF patients and 30 control subjects without a history of inflammatory disease participated in our study. The demographic variables, such as age, sex and body mass index were similar between patients and controls (P > 0.05). We found statistically significant difference in ESR and CRP between FMF patients and controls (P < 0.01, P < 0.05 respectively). There was statistically significant difference in lumbar spine, femoral neck, and total femur BMD between FMF patients and control groups (P < 0.001, P < 0.01, P < 0.01 respectively).Our study indicates that lumbar spine and femoral neck and total femur BMD in patients with FMF may be lower than in healthy subjects.
References
Samuels J, Aksentijevich I, Torosyan Y, Centola M et al (1998) Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and survey of 100 American referrals to the National Institutes of Health. Rev Mol Med 77:268–297
Bakkaloglu A (2003) Familial Mediterranean fever. Pediatr Nephrol 18(9):583–589. doi:10.1007/s00467-003-1185-2
Cattan D, Dervichian M (2002) Familial Mediterranean fever. Rev Prat 52(2):49-54
Tunca M, Kırkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response and evolution of familial Mediterranean fever. Lancet 353:1415. doi:10.1016/S0140-6736(99)00990-3
Korkmaz C, Ozdogan H, Kasapcopur O, Yazıcı H (2002) Acute phase response in familial Mediterranean fever. Ann Rheum Dis 61:79–81. doi:10.1136/ard.61.1.79
Gang N, Drenh JP, Langevitz A et al (1999) Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 26:890–897
Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99–101. doi:10.1007/s10067-002-0682-1
Erken E, Gunesacar R, Ozbek S, Konca K (1996) Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 55:852–855. doi:10.1136/ard.55.11.852
Oktem S, Yavuzsen TU, Sengul B, Akhunlar H, Akar S, Tunca M (2004) Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever patients and their first degree relatives. Clin Exp Rheumatol 22:S34–S36
Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H (1999) Serum soluble intercellular adhesion molecule-1 and interleukin-8 levels in familial Mediterranean fever. J Rheumatol 26:1983–1986
Muller B (2002) Cytokine imbalance in non-immunological chronic disease. Cytokine 18:334–339. doi:10.1006/cyto.2002.0882
Düzova A, Ozaltın F, Ozon A et al (2004) Bone mineral density in children with familial Mediterranean fever. Clin Rheumatol 23:230–234. doi:10.1007/s10067-003-0828-9
Livneh A, Langevitz P, Zemer D et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885. doi:10.1002/art.1780401023
Eisenberg S, Aksentijevich I, Deng Z et al (1998) Diagnosis of familial Mediterranean fever by a molecular genetics method. Ann Intern Med 129:539–542
Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137–1141
Kroger H, Honkanen R, Saarikoski S, Alhava E (1994) Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis—a population based study. Ann Rheum Dis 53:18–23. doi:10.1136/ard.53.1.18
Franck H, Meurer T, Hofbauer LC (2004) Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. J Rheumatol 31:2236–2241
Bicer A, Tursen U, Kaya TI et al (2004) Bone mineral density in patients with Behçet’s disease. Rheumatol Int 24:355–358. doi:10.1007/s00296-003-0381-5
Grcevic D, Katavic V, Lukic IK, Kovacic N, Lorenzo JA, Marusic A (2001) Cellular and molecular interactions between immune system and bone. Croat Med J 42:384–392
Lane NE, Rehman Q (2002) Osteoporosis in the rheumatic disease patient. Lupus 11:675–679. doi:10.1191/0961203302lu261oa
Schattner A, Lachmi M, Livneh A, Pras M, Hahn T (1991) Tumor necrosis factor in familial Mediterranean fever. Am J Med 90:434–438
Mege JL, Dilsen N, Sanguedolce V et al (1993) Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet’s disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 20:1544–1549
Manolagas SC (1995) Role of cytokines in bone resorption. Bone 16(Suppl 1):63–67. doi:10.1016/8756-3282(95)00180-L
Dessein PH, Joffe BI, Stanwix AE (2004) High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis. J Rheumatol 31:1095–1097
Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454. doi:10.1056/NEJM199902113400607
Grisar J, Bernecker PM, Aringer M et al (2002) Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. J Rheumatol 29:1430–1436
Laan R, Buijs W, Draad M et al (1991) Bone mineral density in rheumatoid arthritis: influence of disease activity and functional capacity. Arthritis Rheum 34:S180. doi:10.1002/art.1780340208
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yildirim, K., Karatay, S., Cetinkaya, R. et al. Bone mineral density in patients with familial Mediterranean fever. Rheumatol Int 30, 305–308 (2010). https://doi.org/10.1007/s00296-009-0950-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-0950-3